These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 30054572)

  • 1. LDL quality influences CAD progression.
    Fernandez-Ruiz I
    Nat Rev Cardiol; 2018 Oct; 15(10):582. PubMed ID: 30054572
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).
    Vakkilainen J; Steiner G; Ansquer JC; Aubin F; Rattier S; Foucher C; Hamsten A; Taskinen MR;
    Circulation; 2003 Apr; 107(13):1733-7. PubMed ID: 12665498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial.
    Rosenson RS; Otvos JD; Freedman DS
    Am J Cardiol; 2002 Jul; 90(2):89-94. PubMed ID: 12106834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untargeted Mass Spectrometry Lipidomics identifies correlation between serum sphingomyelins and plasma cholesterol.
    Zalloua P; Kadar H; Hariri E; Abi Farraj L; Brial F; Hedjazi L; Le Lay A; Colleu A; Dubus J; Touboul D; Matsuda F; Lathrop M; Nicholson JK; Dumas ME; Gauguier D
    Lipids Health Dis; 2019 Feb; 18(1):38. PubMed ID: 30711004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical markers of vasospastic coronary artery disease.
    Yamaguchi H; Homma Y; Handa S
    Nutr Metab Cardiovasc Dis; 2003 Dec; 13(6):365-71. PubMed ID: 14979683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between level of circulating modified LDL and the extent of coronary artery disease in type 2 diabetic patients.
    El-Bassiouni EA; Helmy MH; El-Zoghby SM; El-Nabi Kamel MA; Hosny RM
    Br J Biomed Sci; 2007; 64(3):109-16. PubMed ID: 17910279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits.
    Holvoet P; Collen D
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2376-82. PubMed ID: 9409204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating electronegatively charged low-density lipoprotein in patients with angiographically documented coronary artery disease.
    Tomasik A; Jacheć W; Skrzep-Poloczek B; Widera-Romuk E; Wodniecki J; Wojciechowska C
    Scand J Clin Lab Invest; 2003; 63(4):259-65. PubMed ID: 12940633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between small dense low-density lipoprotein levels and coronary artery disease in chronic hemodialysis patients.
    Yeo Y; Byun SW; Lee JY; Min WK; Park JS; Kim SB
    Am J Nephrol; 2009; 30(3):310-4. PubMed ID: 19546529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidomic analysis of plasma lipoprotein fractions in myocardial infarction-prone rabbits.
    Takeda H; Koike T; Izumi Y; Yamada T; Yoshida M; Shiomi M; Fukusaki E; Bamba T
    J Biosci Bioeng; 2015 Oct; 120(4):476-82. PubMed ID: 26162515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dense low density lipoproteins and coronary artery disease.
    Krauss RM
    Am J Cardiol; 1995 Feb; 75(6):53B-57B. PubMed ID: 7863975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.
    Kwon SW; Yoon SJ; Kang TS; Kwon HM; Kim JH; Rhee J; Lee SJ; Park JK; Lim JY; Yoon YW; Hong BK
    Yonsei Med J; 2006 Jun; 47(3):405-14. PubMed ID: 16807992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.
    Zambon A; Hokanson JE; Brown BG; Brunzell JD
    Circulation; 1999 Apr; 99(15):1959-64. PubMed ID: 10208998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized-LDL is a useful marker for predicting the very early coronary artery disease and cardiovascular outcomes.
    Zhao X; Zhang HW; Xu RX; Guo YL; Zhu CG; Wu NQ; Gao Y; Li JJ
    Per Med; 2018 Nov; 15(6):521-529. PubMed ID: 30362886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
    Syvänne M; Nieminen MS; Frick MH; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Ehnholm C; Taskinen MR
    Circulation; 1998 Nov; 98(19):1993-9. PubMed ID: 9808595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
    J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease.
    Cominacini L; Garbin U; Pastorino AM; Davoli A; Campagnola M; De Santis A; Pasini C; Faccini GB; Trevisan MT; Bertozzo L
    Atherosclerosis; 1993 Feb; 99(1):63-70. PubMed ID: 8461061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between plasma adiponectin and small, dense low density lipoprotein in patients with coronary artery disease].
    Chen G; Qin Q; Li Y; Ren B; Lu YR; Kou L; Yang N; Feng JP; Zhao BR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Sep; 40(9):752-6. PubMed ID: 23141087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia.
    Park JW; Merz M; Braun P
    Atherosclerosis; 1998 Aug; 139(2):401-9. PubMed ID: 9712348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.